The Central and Eastern Europe Fund, Inc.
NYSE:CEE
10.72 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 18.153 | -175.719 | 91.231 | -53.854 | 38.713 | -0.164 | 43.152 | -20.528 | 6.523 | 8.868 | 13.726 | 15.686 | 0 |
Cost of Revenue
| 0.425 | 0.856 | 1.902 | 1.796 | 1.997 | 2.079 | 2.013 | 1.784 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 17.728 | -176.575 | 89.329 | -55.65 | 36.716 | -2.243 | 41.139 | -22.312 | 6.523 | 8.868 | 13.726 | 15.686 | 0 |
Gross Profit Ratio
| 0.977 | 1.005 | 0.979 | 1.033 | 0.948 | 13.652 | 0.953 | 1.087 | 1 | 1 | 1 | 1 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.457 | 0.843 | 0.974 | 0.976 | 1.128 | 1.165 | 1.222 | 2.19 | 2.742 | 4.288 | 5.288 | 5.564 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.046 | 0.053 | 0.058 | 0.074 | 0 |
SG&A
| 0.457 | 0.843 | 0.974 | 0.976 | 1.128 | 1.165 | 1.222 | -0 | 2.788 | 4.341 | 5.346 | 5.638 | 0 |
Other Expenses
| 17.962 | -0.135 | 0.01 | 0.011 | 0.01 | 0.01 | 0.011 | 7.758 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0.287 | 0.708 | 0.984 | 0.987 | 1.138 | 1.175 | 1.233 | 2.618 | 54.857 | 96.463 | 13.362 | 7.074 | 0 |
Operating Income
| 17.866 | -176.427 | 90.247 | -54.842 | 37.575 | -1.34 | 41.919 | 3.4 | 3.735 | 4.527 | 8.38 | 10.048 | 0 |
Operating Income Ratio
| 0.984 | 1.004 | 0.989 | 1.018 | 0.971 | 8.154 | 0.971 | -0.166 | 0.573 | 0.511 | 0.611 | 0.641 | 0 |
Total Other Income Expenses Net
| 0.015 | -0.012 | -0.012 | -0.079 | 0.001 | -0 | 0 | 0 | -52.069 | -92.122 | 18.708 | -1.436 | 0 |
Income Before Tax
| 17.866 | -176.427 | 90.247 | -54.842 | 37.575 | -1.34 | 41.919 | 8.242 | -48.334 | -87.595 | 27.088 | 8.612 | 0 |
Income Before Tax Ratio
| 0.984 | 1.004 | 0.989 | 1.018 | 0.971 | 8.154 | 0.971 | -0.401 | -7.41 | -9.877 | 1.973 | 0.549 | 0 |
Income Tax Expense
| 1.842 | 1.898 | 5.763 | 6.568 | 8.938 | -0.161 | 3.962 | -33.803 | -52.069 | -92.122 | 18.708 | -1.436 | 0 |
Net Income
| 17.866 | -176.427 | 90.247 | -54.842 | 37.575 | -1.34 | 41.919 | 8.338 | -48.334 | -87.595 | 27.088 | 8.612 | 0 |
Net Income Ratio
| 0.984 | 1.004 | 0.989 | 1.018 | 0.971 | 8.154 | 0.971 | -0.406 | -7.41 | -9.877 | 1.973 | 0.549 | 0 |
EPS
| 2.86 | -28.36 | 14.33 | -8.21 | 5.6 | -0.23 | 5.61 | 1.01 | -5.91 | -9.37 | 2.41 | 0.66 | 0 |
EPS Diluted
| 2.86 | -28.36 | 14.33 | -8.21 | 5.6 | -0.23 | 5.61 | 7,848,079 | -5.91 | -9.37 | 2.41 | 0.66 | 0 |
EBITDA
| 17.866 | -176.427 | 90.247 | -54.842 | 37.575 | -1.34 | 41.919 | -28.866 | -52.069 | -92.122 | 18.708 | -1.436 | 0 |
EBITDA Ratio
| 0.984 | 1.004 | 0.989 | 1.018 | 0.971 | 8.154 | 0.971 | 1.406 | -7.983 | -10.388 | 1.363 | -0.092 | 0 |